I've decided to sell out of Avita. I made a spreadsheet of...

I've decided to sell out of Avita.

I made a spreadsheet of companies I'm in or interested in summarising measures one of which was cash and cash burn. Avita cannot last another quarter all else being equal.

Another measure was potential market revenue. Avita was the worst in this as really we have no idea. They say a 5B market but that's like saying furniture is a 5B market when you sell chairs. Even then nobody buys their chairs in markets they currently service, so how this can be seen as a profitable indicator in the one they are trying to enter (which does have a risk of non immediate approval). While it might not be a rejection it may be conditional.

Finally, how much they might actually make if they do manage to sell product is anyone's guess, as is how much uptake and demand there is.

You could buy hoping fda approval goes smooth and sell if it goes up, but why risk it. Anyway the market might then assess the business revenue value and might actually dump it.

Management is very poor too.

Nothing really appealing as an investor but a lot of red flags.